Colorectal cancer is a heterogeneous disease, with at least three well-known major, molecularly defined groups: the chromosomal instable, the microsatellite instable and the CpG island methylator phenotype. Although these groups differ in pathology, outcome and response to therapy, this classification is not used in clinical management. Two recent studies might change this perception.
This is a preview of subscription content, log in via an institution to check access.
References
De Sousa e Melo, F. et al. Poor-prognosis colon cancer is defined by a molecularly distinct subtype and develops from serrated precursor lesions. Nat. Med. 19, 614–618 (2013).
Sadanandam, A. et al. A colorectal cancer classification system that associates cellular phenotype and responses to therapy. Nat. Med. 19, 619–625 (2013).
Guastadisegni, C., Colafranceschi, M., Ottini, L. & Dogliotti, E. Microsatellite instability as a marker of prognosis and response to therapy: a meta-analysis of colorectal cancer survival data. Eur. J. Cancer 46, 2788–2798 (2010).
van Krieken, J. H., Jansen, C., Hebeda, K. M. & Groenen, P. J. Biomarkers as disease definition: mantle cell lymphoma as an example. Proteomics Clin. Appl. 4, 922–925 (2010).
Snover, D. C., Ahnen, D. J., Burt, R. W. & Odze, R. D. in WHO Classification of Tumours of the Digestive System (eds Bosman, F. T., Carneiro, F., Hruban, R. H. & Theise, N. D.) 160–165 (WHO Press, 2010).
Gaiser, T. et al. Molecular patterns in the evolution of serrated lesion of the colorectum. Int. J. Cancer 132, 1800–1810 (2013).
Werling, R. W., Yaziji, H., Bacchi, C. E. & Gown, A. M. CDX2, a highly sensitive and specific marker of adenocarcinomas of intestinal origin: an immunohistochemitcal survey of 476 primary and metastatic carcinomas. Am. J. Surg. Pathol. 27, 303–310 (2003).
Hill, L., Browne, G. & Tulchinsky, E. ZEB/miR-200 feedback loop: at the crossroads of signal transduction in cancer. Int. J. Cancer 132, 745–754 (2013).
Gosens, M. J., van Kempen, L. C., van de Velde, C. J., van Krieken, J. H. & Nagtegaal, I. D. Loss of membranous Ep-CAM in budding colorectal carcinoma cells. Mod. Pathol. 20, 221–232 (2007).
Benson, A. B. 3rd et al. American Society of Clinical Oncology recommendations on adjuvant chemotherapy for stage II colon cancer. J. Clin. Oncol. 22, 3408–3419 (2004).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Nagtegaal, I., van Krieken, J. Is the new era of colorectal cancer classification finally here?. Nat Rev Gastroenterol Hepatol 10, 391–393 (2013). https://doi.org/10.1038/nrgastro.2013.90
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrgastro.2013.90
- Springer Nature Limited